Elevance Health, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Gail Koziara Boudreaux
- Full Time Employees
- 97,100
- Sector
- Health services
- Industry
- Managed health care
- Address
- 220 Virginia Avenue Indianapolis IN United States 46204
- IPO Date
- Oct 30, 2001
- CIK
- 0001156039
- Website
- elevancehealth.com
- Similar Companies
- Business
- Elevance Health Inc. (NYSE: ELV) operates as a leading health benefits company in the United States, providing a comprehensive portfolio of medical, dental, vision, pharmaceutical, behavioral health, long-term care, disability, and life insurance plans through affiliated brands including Anthem Blue Cross and Blue Shield in 14 states, Wellpoint Medicaid plans, Carelon services, Amerigroup, and others; it also delivers advanced healthcare solutions such as pharmacy benefit management via CarelonRx, clinical care coordination, digital health tools, primary care enablement, and whole-person care addressing social drivers of health. Headquartered in Indianapolis, Indiana, the company traces its origins to 1946 through predecessor entities like Anthem and WellPoint, which merged in 2004, and rebranded from Anthem Inc. to Elevance Health in June 2022 to reflect its focus on elevating health outcomes. Elevance Health serves approximately 47 million medical members nationwide, with operations spanning commercial employer-sponsored plans, individual coverage, Medicare Advantage, and Medicaid programs across multiple states including California, Florida, Georgia, Indiana, Kentucky, Missouri, New York, Ohio, Texas, and Puerto Rico via subsidiaries like MMM; it targets employers, individuals, families, government programs, and complex-needs populations through segments encompassing Health Benefits, CarelonRx, Carelon Services, and other corporate activities. The company has pursued aggressive expansion in specialty care and home-based services, including the 2024 acquisition of Paragon Healthcare for infusion therapies and CareBridge for home health management; it acquired Kroger Specialty Pharmacy in 2024 to bolster CarelonRx's infusion and mail-order capabilities, alongside earlier purchases of BioPlus Specialty Pharmacy and opening new dispensing centers. In April 2024, Elevance Health formed a strategic partnership with Clayton, Dubilier & Rice, integrating Carelon Health assets with apree health and Millennium Physician Group to innovate primary care delivery across U.S. regions. Recent initiatives encompass expanding behavioral health interventions and external partnerships under Carelon to manage medical costs, deepening AI integrations via a partnership with OpenAI announced in Q3 2025, scaling pharmacy home delivery and specialty services, enhancing Star ratings through member engagement, and broadening access to doula care and histotripsy treatments for liver tumors for over 45 million members; the company also rebranded Amerigroup to Wellpoint in 2024 and continues investing in digital automation and value-based care principles to drive long-term growth amid Medicaid dynamics.
Company News
Elevance Health: Better Results, But Not Enough To Buy
Elevance: 3 Key Takeaways for Long-Term Investors
2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
What Elevance Health (ELV) Said on Its Q3 Earnings Call
Compared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key Metrics
Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates
Elevance Health Names Jeff Park President of Carelon
Elevance Health Raises Yearly Outlook as Profit, Revenue Rise
Elevance lifts 2026 profit forecast on better medical cost management
Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?
Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics
Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review
2 Stocks to Buy Hand Over Fist in October
ELV or DHR: Which Is the Better Value Stock Right Now?
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?